Ledger.Open graph →
SEC Form D · filed January 31, 2013

Corridor Pharmaceuticals, Inc

Offering
$1.8M
Sold
$1.6M
Exemption
—
Industry
Biotechnology
Location
Baltimore, MD
Type
—

People & firms on this filing (11)

David King · Burlington, NCDirectorLeonard P. Gage · Lutherville, MDDirectorBrian Halak · Princeton, NJDirectorPeter Greenleaf · New Haven, CTDirectorAnne Shiflett · Baltimore, MDExecMark Strobeck · Baltimore, MDExec · DirectorLeonard P. Gage · Baltimore, MDDirectorBrian Halak · BELLEVUE, WADirectorDavid King · Calgary, Alberta, CanadaDirectorPeter Greenleaf · Waltham, MADirectorAnne Shiflett · Gaithersburg, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗